<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26583" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pancytopenia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chiravuri</surname>
            <given-names>Shalini</given-names>
          </name>
          <aff>Conemaugh Memorial Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shalini Chiravuri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26583.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pancytopenia is defined as a decrease in all three hematologic cell lines. The condition is not a disease in itself but a common pathway caused by various etiologies that can be infectious, autoimmune, genetic, nutritional, and/or malignant. Determining the cause of pancytopenia is a challenge and is key in determining the proper treatment regimen and estimating prognosis. Pancytopenia could be a result of decreased production of the cells or increased destruction. Anyone presenting with pancytopenia requires a thorough evaluation to identify the underlying etiology. This activity reviews the most common etiologies of pancytopenia, outlines potential pathways in determining the underlying diagnosis, and highlights the interprofessional team's importance in evaluating and treating these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of pancytopenia.</p></list-item><list-item><p>Describe the evaluation of patients with pancytopenia.</p></list-item><list-item><p>Review the management options available for pancytopenia.</p></list-item><list-item><p>Explain the differentials or pancytopenia and their management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26583&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26583">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26583.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pancytopenia is a hematologic condition characterized by a decrease in all three peripheral blood cell lines. It is characterized by a hemoglobin value of less than 12 g/dL in women and 13 g/dL in men, platelets of less than 150,000 per mcL, and leukocytes of less than 4000 per ml (or absolute neutrophil count of less than 1800 per ml).<xref ref-type="bibr" rid="article-26583.r1">[1]</xref><xref ref-type="bibr" rid="article-26583.r2">[2]</xref>&#x000a0;However, these thresholds mainly depend on age, sex, race, and varying clinical scenarios.</p>
        <p>Leukopenia is primarily seen as neutropenia since neutrophils constitute the majority of leukocytes. Pancytopenia is not a disease but a manifestation of other underlying conditions.<xref ref-type="bibr" rid="article-26583.r3">[3]</xref> It is commonly associated with multiple benign and malignant conditions.<xref ref-type="bibr" rid="article-26583.r1">[1]</xref>&#x000a0;Pancytopenia could be a result of decreased production of the cells or increased destruction. Anyone presenting with pancytopenia requires a thorough evaluation to identify the underlying etiology.</p>
      </sec>
      <sec id="article-26583.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of pancytopenia can be broadly categorized as a central type that involves production disorders or a peripheral type that involves disorders of increased destruction.<xref ref-type="bibr" rid="article-26583.r4">[4]</xref>&#x000a0;These causes could contribute to pancytopenia independently or as a combination.</p>
        <p><bold>Decreased production (central type):</bold> Pancytopenia due to decreased production is mainly secondary to nutritional deficiencies. Pancytopenia caused by bone marrow failure is known as aplastic anemia. Aplastic anemia could be idiopathic/autoimmune, secondary to infections (such as parvovirus B19, hepatitis, human immunodeficiency virus (HIV), cytomegalovirus, or Epstein-Barr virus), after drug toxicity, or chemotherapeutic agents (methotrexate, dapsone, carbimazole, carbamazepine, chloramphenicol). Pancytopenia can also be related to inadequate intake (as seen in eating disorders and alcoholics) or malabsorption.<xref ref-type="bibr" rid="article-26583.r5">[5]</xref></p>
        <p><bold>Bone marrow infiltration/replacement:</bold> The production of cell lines is also impaired when the bone marrow is infiltrated by malignancies (lymphoma, leukemia, multiple myeloma) or granulomatous disorders. Metastatic tumors can also cause bone marrow replacement late in the disease, thus producing pancytopenia.</p>
        <p><bold>Increased destruction (peripheral type):</bold> Peripheral destruction of cells can be associated with many autoimmune conditions (such as systemic lupus erythematosus, rheumatoid arthritis) and splenic sequestration (alcoholic liver cirrhosis, HIV, tuberculosis, malaria). Hypersplenism affects platelets and erythrocytes more than leukocytes.</p>
        <p>With the current <bold>Covid-19 pandemic</bold>, pancytopenia has been reported secondary to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).<xref ref-type="bibr" rid="article-26583.r6">[6]</xref><xref ref-type="bibr" rid="article-26583.r7">[7]</xref><xref ref-type="bibr" rid="article-26583.r8">[8]</xref>&#x000a0;Bone marrow aspiration had shown viral infection and infiltration with SARS-CoV-2.<xref ref-type="bibr" rid="article-26583.r9">[9]</xref></p>
        <p>Despite extensive workup, a subset of patients has unexplained cytopenia, classified as <italic toggle="yes">idiopathic cytopenias of unknown significance</italic>.<xref ref-type="bibr" rid="article-26583.r10">[10]</xref></p>
        <p>The table below summarizes the causes of pancytopenia according to the mechanisms involved:</p>
        <table-wrap id="article-26583.table0" position="float" orientation="portrait">
          <table style="height: 282px; width: 613px;" border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td style="width: 264px;" rowspan="1" colspan="1">
<bold>Mechanisms</bold>
</td>
                <td style="width: 264px;" rowspan="1" colspan="1">
<bold>Causes</bold>
</td>
              </tr>
              <tr>
                <td style="width: 264px;" rowspan="1" colspan="1">
<bold>Decreased production (central type)</bold>
</td>
                <td style="width: 264px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Autoimmune disorders (e.g., systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], sarcoidosis)</p></list-item><list-item><p>Hemophagocytic lymphohistiocytosis (HLH)</p></list-item><list-item><p>Aplastic anemia/paroxysmal nocturnal hemoglobinuria</p></list-item><list-item><p>Drugs
<list list-type="bullet"><list-item><p>Cytotoxic drugs</p></list-item><list-item><p>Idiosyncratic reactions to medications</p></list-item></list>
</p></list-item><list-item><p>Large granular lymphocyte leukemia</p></list-item><list-item><p>Nutritional abnormalities (B12 and folate deficiencies, excessive alcohol, malnutrition)</p></list-item><list-item><p>Viral infections<xref ref-type="bibr" rid="article-26583.r11">[11]</xref><xref ref-type="bibr" rid="article-26583.r12">[12]</xref></p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 264px;" rowspan="1" colspan="1">
<bold>Bone marrow infiltration/replacement</bold>
</td>
                <td style="width: 264px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Non-malignant
<list list-type="bullet"><list-item><p>Myelofibrosis</p></list-item><list-item><p>Infectious (e.g., fungal, tuberculous)</p></list-item><list-item><p>Storage diseases</p></list-item></list>
</p></list-item></list>
<list list-type="bullet"><list-item><p>Malignant
<list list-type="bullet"><list-item><p>Acute leukemias</p></list-item><list-item><p>Chronic leukemias/myeloproliferative neoplasms (MPN)</p></list-item><list-item><p>Myelodysplastic syndromes (MDS)</p></list-item><list-item><p>Multiple myeloma</p></list-item><list-item><p>Metastatic cancer</p></list-item></list>
</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 264px;" rowspan="1" colspan="1">
<bold>Increased destruction (peripheral type)</bold>
</td>
                <td style="width: 264px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Consumption
<list list-type="bullet"><list-item><p>Disseminated intravascular coagulation (e.g., associated with sepsis, acute promyelocytic leukemia)</p></list-item></list>
</p></list-item><list-item><p>Splenomegaly
<list list-type="bullet"><list-item><p>Portal hypertension/cirrhosis</p></list-item><list-item><p>Infections (e.g., EBV)</p></list-item><list-item><p>Autoimmune disorders (e.g., SLE, RA/Felty syndrome)</p></list-item><list-item><p>Myelofibrosis with myeloid metaplasia</p></list-item><list-item><p>Storage diseases (e.g., Gaucher)</p></list-item><list-item><p>Malignancies (e.g., lymphomas, MPN)</p></list-item></list>
</p></list-item></list>
&#x000a0;</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>&#x000a0;Table 1. Mechanisms of pancytopenia</bold>
</p>
        <table-wrap id="article-26583.table1" position="float" orientation="portrait">
          <table style="width: 506px;" cellspacing="0">
            <tbody>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">
<bold>Category</bold>
</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<bold>Drugs</bold>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Nonsteroidal anti-inflammatory drugs</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Aspirin</p></list-item><list-item><p>Salicylates</p></list-item><list-item><p>Ibuprofen</p></list-item><list-item><p>Indomethacin</p></list-item><list-item><p>Diclofenac</p></list-item><list-item><p>Sulindac</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Cardiovascular (including diuretics)</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Aspirin</p></list-item><list-item><p>Lisinopril</p></list-item><list-item><p>Amiodarone</p></list-item><list-item><p>Nifedipine</p></list-item><list-item><p>Captopril</p></list-item><list-item><p>Quinidine</p></list-item><list-item><p>Thiazides</p></list-item><list-item><p>Acetazolamide</p></list-item><list-item><p>Furosemide</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Antimicrobials</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Albendazole</p></list-item><list-item><p>Cidofovir</p></list-item><list-item><p>Dapsone</p></list-item><list-item><p>Ganciclovir &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p></list-item><list-item><p>Foscarnet</p></list-item><list-item><p>Sulfonamides</p></list-item><list-item><p>Quinidine</p></list-item><list-item><p>Quinine &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p></list-item><list-item><p>Zidovudine</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Anti-gout</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Allopurinol</p></list-item><list-item><p>Colchicine</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Anti-epileptics</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Carbamazepine</p></list-item><list-item><p>Fosphenytoin</p></list-item><list-item><p>Phenytoin</p></list-item><list-item><p>Phenobarbital</p></list-item><list-item><p>Valproate</p></list-item><list-item><p>Levetiracetam</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Rheumatologic</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Leflunomide</p></list-item><list-item><p>Methotrexate</p></list-item><list-item><p>Sulfasalazine</p></list-item><list-item><p>Penicillamine</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Psychiatric</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Bupropion</p></list-item><list-item><p>Lithium</p></list-item><list-item><p>Valproate</p></list-item><list-item><p>Carbamazepine&#x000a0;</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 366px;" rowspan="1" colspan="1">Anti-thyroid</td>
                <td style="width: 132px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Methimazole</p></list-item><list-item><p>Propylthiouracil</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Table 2. Drugs causing pancytopenia</bold>
</p>
      </sec>
      <sec id="article-26583.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Pancytopenia incidence frequently has a bi-modal presentation in children and adults in the 3rd and 4th decades. Literature has reported a between 1.4&#x000a0;and&#x000a0;2.6&#x000a0;to 1 male to female predominance.&#x000a0;While conditions such as multiple myeloma and myelodysplastic syndrome are more prevalent in older patients, acute leukemia and parvovirus B19 infection are more common in younger patients.</p>
        <p>In North America, the most common etiologies are myeloid neoplasms (acute myeloid leukemia, myelodysplasia, non-Hodgkin lymphoma, hairy cell leukemia, and precursor B acute lymphoblastic leukemia), followed by aplastic anemia, megaloblastic anemia, and HIV infections.<xref ref-type="bibr" rid="article-26583.r13">[13]</xref></p>
        <p>Geographic and sociocultural influences determine the significant pancytopenia causes, especially for megaloblastic anemia.<xref ref-type="bibr" rid="article-26583.r13">[13]</xref><xref ref-type="bibr" rid="article-26583.r14">[14]</xref>&#x000a0;For megaloblastic anemia, there is usually no gender predominance.&#x000a0;There seem to be more cases in the East than in the West, most likely due to the higher incidence of infections and drugs causing pancytopenia used in developing countries.</p>
        <p>A study from 2013 in India showed that the most common causes are hypersplenism, infections, myelosuppression (cancer, chemotherapy, drug toxicity, or radiotherapy), and megaloblastic anemia.<xref ref-type="bibr" rid="article-26583.r3">[3]</xref> A previous study in India showed megaloblastic anemia as the most frequent cause, followed by aplastic anemia.<xref ref-type="bibr" rid="article-26583.r14">[14]</xref> In Mexico, the most common causes are myelodysplastic syndromes and megaloblastic anemia, followed by acute myeloblastic leukemia, acute lymphoblastic leukemia, hypersplenism, and aplastic anemia.&#x000a0;In Turkey, the most common cause is megaloblastic anemia, followed by acute myeloid leukemia and aplastic anemia.<xref ref-type="bibr" rid="article-26583.r2">[2]</xref></p>
      </sec>
      <sec id="article-26583.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The underlying pathophysiology depends on the cause of pancytopenia. The pathophysiology of aplastic anemia is an autoimmune-mediated T-cell activation, which leads to the destruction of the hematopoietic stem cells. Bone marrow suppression is also caused by the direct cytotoxic effects of medications such as methotrexate, anticonvulsants, and chemotherapeutic agents. Ineffective hematopoiesis is seen in the bone marrow of myelodysplastic syndrome.</p>
        <p>Sepsis causes pancytopenias through several mechanisms (marrow suppression, hypersplenism, and consumptive coagulopathy), which usually act in combination. The virus causes pancytopenia through several mechanisms that modulate the hematopoietic stem cells.<xref ref-type="bibr" rid="article-26583.r15">[15]</xref>&#x000a0;A massive cytokine storm syndrome had been implicated in cases of SARS-CoV-2.<xref ref-type="bibr" rid="article-26583.r12">[12]</xref><xref ref-type="bibr" rid="article-26583.r16">[16]</xref><xref ref-type="bibr" rid="article-26583.r8">[8]</xref>&#x000a0;Paroxysmal nocturnal hemoglobinuria is a genetic disease caused by the absence of glycophosphatidylinositol-linked proteins, such as CD55 and CD59, which prevent complement-mediated destruction of the cells. It involves the mutation of phosphatidylinositol glycan class A proteins.</p>
      </sec>
      <sec id="article-26583.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation can be variable, with mild pancytopenia being asymptomatic to life-threatening emergencies in severe pancytopenia. Patients can present with manifestations of any of the decreased cell lines. Anemia can present as shortness of breath, fatigue, and chest pain. Leukopenia manifests as increased infections, while thrombocytopenia presents with bruising, petechiae, and a propensity for bleeding. Patients with severe neutropenia can present with severe infections. Patients with underlying liver disease can present with anorexia, nausea, or lethargy. Patients with splenic sequestration can present with left upper quadrant pain. Constitutional symptoms can be seen in patients with underlying autoimmune disorders or malignancies.</p>
        <p>History is of utmost importance in the evaluation of pancytopenia. This should include investigating symptoms of autoimmune conditions, malignancies, recent infections, medications, chemotherapy, or radiation therapy. A detailed history of nutritional status should be taken. It should be noted that the presentation of malabsorption could be subtle, and pancytopenia may be the only presentation. Family history should be taken into account as well for inherited aplastic anemia.&#x000a0;</p>
        <p>Physical examination may reveal pallor, petechiae, ulcers, and rash. Signs of underlying liver disease may be seen in patients with cirrhosis. Splenomegaly may be seen in patients with splenic sequestration. Lymphadenopathy can be seen in patients with infections and lymphoma. Attention must be paid to signs of nutritional deficiencies in patients with eating disorders and alcoholism. The neurological examination is essential as it may show impairment of proprioception with a positive Romberg test and ataxia, suggesting subacute combined degeneration of the spinal cord secondary to vitamin B12 (cobalamin) deficiency and macrocytic anemia.<xref ref-type="bibr" rid="article-26583.r17">[17]</xref></p>
      </sec>
      <sec id="article-26583.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The initial workup includes a complete blood count, along with a reticulocyte count. This will help to determine if the pancytopenia is secondary to decreased production. The mean corpuscular volume would point towards megaloblastic anemia. A peripheral blood smear can show abnormal cells such as blasts, dysplastic leukocytes, and immature cells. These abnormal cells may be related to conditions described in table 3. The diagnosis related to abnormal cells may require further investigations:</p>
        <list list-type="order">
          <list-item>
            <p>Bone marrow aspirate and biopsy</p>
          </list-item>
          <list-item>
            <p>Cytogenetic testing (fluorescent in situ hybridization [FISH] or karyotype) of bone marrow or peripheral blood</p>
          </list-item>
          <list-item>
            <p>Flow cytometry of bone marrow and/or&#x000a0;peripheral blood</p>
          </list-item>
          <list-item>
            <p>Molecular studies (e.g., mutation analysis, gene expression profiling)</p>
          </list-item>
          <list-item>
            <p>The workup should also include vitamin B12 and folate levels, liver chemistry, and lactate dehydrogenase.</p>
          </list-item>
        </list>
        <p>Infectious workup should be done as pancytopenia can be associated with infections such as HIV,&#x000a0;malaria,&#x000a0;and tuberculosis.<xref ref-type="bibr" rid="article-26583.r18">[18]</xref><xref ref-type="bibr" rid="article-26583.r19">[19]</xref><xref ref-type="bibr" rid="article-26583.r20">[20]</xref></p>
        <p>In pancytopenia cases secondary to an acute viral infection, no further workup should be performed as most resolved rapidly. Follow-up laboratories can be performed to confirm the resolution of the pancytopenia. Similarly, in severe infections with sepsis, further workup should not be performed as pancytopenia is most likely the result of sepsis. The termination of the infection/sepsis will correct the pancytopenia.</p>
        <p>Further evaluation for undiagnosed hepatitis&#x000a0;and autoimmune conditions or malignancies should be pursued if suspected.<xref ref-type="bibr" rid="article-26583.r21">[21]</xref> Serum calcium and parathyroid hormone levels can help patients with a negative workup, as there are cases of hyperparathyroidism causing pancytopenia.<xref ref-type="bibr" rid="article-26583.r22">[22]</xref><xref ref-type="bibr" rid="article-26583.r23">[23]</xref>&#x000a0;A thyroid profile should also be obtained, as hyperthyroidism is associated with pancytopenia.<xref ref-type="bibr" rid="article-26583.r24">[24]</xref><xref ref-type="bibr" rid="article-26583.r25">[25]</xref></p>
        <p>Bone marrow aspiration and biopsy can be done if no specific etiology is found to evaluate the status of the bone marrow stem cells. Bone marrow aspiration establishes the diagnosis of pancytopenia in 75% of cases.<xref ref-type="bibr" rid="article-26583.r13">[13]</xref><xref ref-type="bibr" rid="article-26583.r26">[26]</xref> The most common etiologies found are hypoplastic marrow, followed by megaloblastic anemia and hematological malignancies.&#x000a0;Pathological examination of the bone marrow biopsy is helpful in malignant etiologies. It can show a clonal population of cells, primary/secondary malignant cells, acellular marrow, fibroblasts, granulomas from tuberculosis, sarcoidosis, or fungal infections.</p>
        <table-wrap id="article-26583.table2" position="float" orientation="portrait">
          <table style="height: 350px; width: 830.484px;" border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Type of cells</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">
<bold>Associated conditions</bold>
</td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Circulating blasts</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Acute leukemias, hairy cell leukemia, or other hematologic malignancies<xref ref-type="bibr" rid="article-26583.r13">[13]</xref></td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Dysplastic leukocytes, including pseudo-Pelger-Hu&#x000eb;t cells</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Myelodysplastic syndromes&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Immature myeloid cells, such as promyelocytes, myelocytes, and metamyelocytes</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Myeloproliferative neoplasm (MPN), such as primary myelofibrosis</td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Nucleated red blood cells</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Myelofibrosis or other MPNs</td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Hypersegmented neutrophils</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Deficiencies of folate and/or vitamin B12</td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Schistocytes or other evidence of microangiopathic hemolytic anemia (MAHA)</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Disseminated intravascular coagulation</td>
              </tr>
              <tr>
                <td style="width: 370px;" rowspan="1" colspan="1">
<bold>Leukoerythroblastic appearance of the blood smear, with RBC teardrops, nucleated RBCs, and MAHA</bold>
</td>
                <td style="width: 370.484px;" rowspan="1" colspan="1">Metastatic cancer or&#x000a0;myelofibrosis<xref ref-type="bibr" rid="article-26583.r27">[27]</xref></td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Table 3. Abnormal cells on blood smear with associated conditions</bold>
</p>
      </sec>
      <sec id="article-26583.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is based on the underlying etiology of pancytopenia. Nutritional deficiencies should be corrected. Any offending drug should be discontinued. Treatment for infections such as HIV or tuberculosis should be started immediately. If an autoimmune condition or malignancy is diagnosed, it should be treated. Aplastic anemia secondary to viral infections such as parvovirus is transient and symptomatic treatment should suffice. Treatment options for patients with severe aplastic anemia could include a hematopoietic stem cell transplant and immunosuppression. Hematology referral should be sought for these patients.</p>
        <p>Supportive care for patients includes red blood cell transfusion for anemia to alleviate symptoms and perfuse vital structures. Platelet transfusion is indicated for thrombocytopenia of less than 10,000 per mcL to prevent spontaneous intracranial bleeding. Prompt initiation of broad-spectrum antibiotic therapy is recommended for patients with neutropenic fever or severe neutropenia with an absolute neutrophil count of less than 500 per ml due to the risk of death from sepsis.</p>
      </sec>
      <sec id="article-26583.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Multiple conditions can present with pancytopenia; hence, when someone shows up with pancytopenia, a complete evaluation is performed to detect the cause of pancytopenia. Bone marrow disorders such as aplastic anemia, myelodysplastic syndrome, acute leukemia, myelofibrosis, megaloblastic anemia, paroxysmal nocturnal hemoglobinuria, and Fanconi anemia can present with pancytopenia.</p>
        <p>Fanconi anemia is the most common congenital cause of bone marrow failure with an autosomal recessive inheritance pattern. In myelofibrosis, the bone marrow cells are replaced with fibrotic tissue. Malignancies such as lymphoma, multiple myeloma, and hairy cell leukemia can also present with pancytopenia. Non-bone marrow conditions present with pancytopenia include systemic lupus erythematosus and infections (such as parvovirus B19, Epstein Barr virus, HIV, hepatitis, leishmaniasis, tuberculosis, malaria, and histoplasmosis).<xref ref-type="bibr" rid="article-26583.r3">[3]</xref></p>
      </sec>
      <sec id="article-26583.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of pancytopenia depends on the underlying condition. The prognosis is excellent in conditions like viral infections, where the pancytopenia improves without intervention. The prognosis in patients with myelodysplastic syndrome depends on the degree of pancytopenia and the percentage of blasts in the marrow. Patients receiving chemotherapy or drugs causing pancytopenia (methotrexate, linezolid, or anticonvulsants) may have to discontinue the treatment if alternative agents are available. Most of the time, pancytopenia is reversible with the discontinuation of the therapy.<xref ref-type="bibr" rid="article-26583.r28">[28]</xref></p>
      </sec>
      <sec id="article-26583.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of pancytopenia include an increased risk of infections, life-threatening anemia, and bleeding. Patients presenting with fever will need broad-spectrum antibiotics and antifungals with pan cultures. Supportive transfusions with packed red blood cells and platelets should be initiated promptly if severe anemia or thrombocytopenia with bleeding is present. Other complications include tumor lysis syndrome seen in patients receiving chemotherapy for substantial&#x000a0;tumors like high-grade lymphoma and acute leukemia.<xref ref-type="bibr" rid="article-26583.r29">[29]</xref></p>
      </sec>
      <sec id="article-26583.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Patients with pancytopenia will need a hematology/oncologist consult. Additionally, patients with infections may need an infectious disease consult. Patients with rheumatological conditions and on treatment with methotrexate will need a rheumatology consult. If patients have undiagnosed or newly diagnosed thyroid or hypercalcemia, these patients will need an endocrinology consult.</p>
      </sec>
      <sec id="article-26583.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated about the adverse reactions and toxicities of medications and over-the-counter supplements. The importance of periodic evaluations and blood work must be explained to a patient if started on drugs such as methotrexate or linezolid. In addition, patients with underlying hematologic malignancies (such as multiple myeloma, myelodysplastic syndrome, lymphoma, or acute leukemias) should be cautioned about the possibility of pancytopenia.</p>
        <p>If a patient is found with pancytopenia, the patient should be counseled on the complications of pancytopenia and the increased risk for infections, bleeding, and manifestations of anemia. These patients should also be advised against other medications that may worsen pancytopenia.</p>
      </sec>
      <sec id="article-26583.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Pancytopenia may present with the following emergencies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Neutropenia (new diagnosis or associated with fever/infection)</p>
          </list-item>
          <list-item>
            <p>Metabolic emergencies (e.g., symptomatic&#x000a0;hyperkalemia, hypercalcemia, tumor lysis syndrome)</p>
          </list-item>
          <list-item>
            <p>Disseminated intravascular coagulation</p>
          </list-item>
          <list-item>
            <p>Hemophagocytic lymphohistiocytosis</p>
          </list-item>
          <list-item>
            <p>Abnormal peripheral blood smear (e.g., microangiopathy, blasts)</p>
          </list-item>
          <list-item>
            <p>Severe aplastic anemia</p>
          </list-item>
          <list-item>
            <p>Symptomatic anemia (e.g., cardiac ischemia, hemodynamic instability, worsening congestive heart failure)</p>
          </list-item>
          <list-item>
            <p>Thrombocytopenia (platelets &#x0003c;10,000/microL, or &#x0003c;50,000/microL associated with bleeding)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26583.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pancytopenia is a tricky&#x000a0;manifestation with multiple etiological factors. Patients can present with symptoms of anemia, thrombocytopenia, and leukopenia. History taking is essential in this condition to determine the underlying cause of pancytopenia. While the hospitalist or the primary care provider is&#x000a0;usually the first physician to contact the patient, it is imperative to involve multiple teams and specialists such as hematologists/oncologists, rheumatologists, pathologists, radiologists, and pharmacists. Hematologists help in the diagnosis and management of pancytopenia. They can also perform bone marrow biopsy if the etiology is inconclusive.</p>
        <p>Pathologists and hematologists sometimes work together with these patients. Rheumatologists play a role in managing pancytopenia secondary to autoimmune diseases or the side effects of medications used for autoimmune diseases. Pharmacists help with drugs and dose-dependent adverse reactions. Finally, nurses play a huge role in managing these patients; not only do they monitor the patient's vitals (especially fever), but they also help with patient counseling and education about the adverse effects of the potential culprit drugs.&#x000a0;</p>
        <p>While pancytopenia treatment depends on the underlying cause, improved outcomes are seen with prompt consultation with an interprofessional group of clinicians and specialists,&#x000a0;and nursing&#x000a0;staff, engaging in coordinated activity and open communication to ensure accurate diagnosis and appropriate treatment based on the underlying cause of pancytopenia. This interprofessional approach will yield the most optimal patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-26583.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26583&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26583">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/pancytopenia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26583">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26583/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26583">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26583.s17">
        <title>References</title>
        <ref id="article-26583.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vargas-Carretero</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fernandez-Vargas</surname>
                <given-names>OE</given-names>
              </name>
              <name>
                <surname>Ron-Maga&#x000f1;a</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Padilla-Ortega</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ron-Guerrero</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Barrera-Chairez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Etiology and clinico-hematological profile of pancytopenia: experience of a Mexican Tertiary Care Center and review of the literature.</article-title>
            <source>Hematology</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>399</fpage>
            <page-range>399-404</page-range>
            <pub-id pub-id-type="pmid">30890036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das Makheja</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumar Maheshwari</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kumari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vikash</surname>
              </name>
            </person-group>
            <article-title>The common causes leading to pancytopenia in patients presenting to tertiary care hospital.</article-title>
            <source>Pak J Med Sci</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>1108</fpage>
            <page-range>1108-11</page-range>
            <pub-id pub-id-type="pmid">24353701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Naniwadekar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An etiological reappraisal of pancytopenia - largest series reported to date from a single tertiary care teaching hospital.</article-title>
            <source>BMC Hematol</source>
            <year>2013</year>
            <month>Nov</month>
            <day>06</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">24238033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gnanaraj</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parnes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Go</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Takemoto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Approach to pancytopenia: Diagnostic algorithm for clinical hematologists.</article-title>
            <source>Blood Rev</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>361</fpage>
            <page-range>361-367</page-range>
            <pub-id pub-id-type="pmid">29555368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeshima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kitadate</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nanjyo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kanbayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Anorexia nervosa-associated pancytopenia mimicking idiopathic aplastic anemia: a case report.</article-title>
            <source>BMC Psychiatry</source>
            <year>2018</year>
            <month>May</month>
            <day>25</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>150</fpage>
            <pub-id pub-id-type="pmid">29801443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.</article-title>
            <source>J Thromb Haemost</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>844</fpage>
            <page-range>844-847</page-range>
            <pub-id pub-id-type="pmid">32073213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Samkari</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Karp Leaf</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Dzik</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>JCT</given-names>
              </name>
              <name>
                <surname>Fogerty</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Waheed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goodarzi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bendapudi</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Bornikova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leaf</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Kuter</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Rosovsky</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.</article-title>
            <source>Blood</source>
            <year>2020</year>
            <month>Jul</month>
            <day>23</day>
            <volume>136</volume>
            <issue>4</issue>
            <fpage>489</fpage>
            <page-range>489-500</page-range>
            <pub-id pub-id-type="pmid">32492712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasinathan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sathar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review.</article-title>
            <source>Ann Med Surg (Lond)</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>56</volume>
            <fpage>173</fpage>
            <page-range>173-177</page-range>
            <pub-id pub-id-type="pmid">32637095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Issa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lacassin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Camou</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient.</article-title>
            <source>Ann Oncol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>1418</fpage>
            <page-range>1418-1419</page-range>
            <pub-id pub-id-type="pmid">32615155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steensma</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).</article-title>
            <source>Curr Hematol Malig Rep</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>536</fpage>
            <page-range>536-542</page-range>
            <pub-id pub-id-type="pmid">31696381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;n Pozuelo Ruiz de Pascual</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez Pardo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-D&#x000f3;riga Bonnardeaux</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pancytopenia during SARS-CoV-2 infection.</article-title>
            <source>Med Clin (Barc)</source>
            <year>2020</year>
            <month>Oct</month>
            <day>23</day>
            <volume>155</volume>
            <issue>8</issue>
            <fpage>364</fpage>
            <page-range>364-365</page-range>
            <pub-id pub-id-type="pmid">32753109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Development of pancytopenia in a patient with COVID-19.</article-title>
            <source>J Med Virol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>1219</fpage>
            <page-range>1219-1220</page-range>
            <pub-id pub-id-type="pmid">32990983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devitt</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Lunde</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>New onset pancytopenia in adults: a review of underlying pathologies and their associated clinical and laboratory findings.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2014</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>1099</fpage>
            <page-range>1099-105</page-range>
            <pub-id pub-id-type="pmid">23829306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khunger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Arulselvi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ranga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Talib</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Pancytopenia--a clinico haematological study of 200 cases.</article-title>
            <source>Indian J Pathol Microbiol</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-9</page-range>
            <pub-id pub-id-type="pmid">12785191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Goodell</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response.</article-title>
            <source>Nat Rev Immunol</source>
            <year>2011</year>
            <month>Sep</month>
            <day>09</day>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>685</fpage>
            <page-range>685-92</page-range>
            <pub-id pub-id-type="pmid">21904387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McAuley</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tattersall</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Manson</surname>
                <given-names>JJ</given-names>
              </name>
              <collab>HLH Across Speciality Collaboration, UK</collab>
            </person-group>
            <article-title>COVID-19: consider cytokine storm syndromes and immunosuppression.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Mar</month>
            <day>28</day>
            <volume>395</volume>
            <issue>10229</issue>
            <fpage>1033</fpage>
            <page-range>1033-1034</page-range>
            <pub-id pub-id-type="pmid">32192578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Identification of transcobalamin deficiency with two novel mutations in the TCN2 gene in a Chinese girl with abnormal immunity: a case report.</article-title>
            <source>BMC Pediatr</source>
            <year>2020</year>
            <month>Oct</month>
            <day>06</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>460</fpage>
            <pub-id pub-id-type="pmid">33023511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santiago-Rodr&#x000ed;guez</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Mayor</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Santos</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hunter-Mellado</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Profile of HIV-Infected Hispanics with Pancytopenia.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2015</year>
            <month>Dec</month>
            <day>22</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>ijerph13010038</fpage>
            <pub-id pub-id-type="pmid">26703689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tiresse</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Allaoui</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Multifocal tuberculosis revealed by pancytopenia: about a case].</article-title>
            <source>Pan Afr Med J</source>
            <year>2018</year>
            <volume>31</volume>
            <fpage>92</fpage>
            <pub-id pub-id-type="pmid">31011393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achi</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Ahui</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Anon</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kouassi</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Dje-Bi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kininlman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Pancytopenia: a severe complication of miliary tuberculosis].</article-title>
            <source>Rev Mal Respir</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-7</page-range>
            <pub-id pub-id-type="pmid">23318187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Araki</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yamauchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Eso</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shindo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Seno</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis-associated Aplastic Anemia with Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis.</article-title>
            <source>Intern Med</source>
            <year>2020</year>
            <month>Apr</month>
            <day>15</day>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>1035</fpage>
            <page-range>1035-1040</page-range>
            <pub-id pub-id-type="pmid">31875639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Opie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Omar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sandler</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Primary hyperparathyroidism manifesting with pancytopenia.</article-title>
            <source>Pathology</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>3</issue>
            <fpage>326</fpage>
            <page-range>326-329</page-range>
            <pub-id pub-id-type="pmid">28267996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Son</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism.</article-title>
            <source>Int J Lab Hematol</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>464</fpage>
            <page-range>464-8</page-range>
            <pub-id pub-id-type="pmid">17988303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamid</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Fadul</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Batia</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Yassin</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Graves' Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation.</article-title>
            <source>Case Rep Oncol</source>
            <year>2020</year>
            <season>Jan-Apr</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>295</fpage>
            <page-range>295-298</page-range>
            <pub-id pub-id-type="pmid">32308594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garla</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Abdul Salim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yanes-Cardozo</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Pancytopenia: a rare complication of Graves' disease.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Mar</month>
            <day>09</day>
            <volume>2018</volume>
            <pub-id pub-id-type="pmid">29525760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sayami</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adhikari</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Panta</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Bone marrow examination in cases of pancytopenia.</article-title>
            <source>JNMA J Nepal Med Assoc</source>
            <year>2008</year>
            <season>Jan-Mar</season>
            <volume>47</volume>
            <issue>169</issue>
            <fpage>12</fpage>
            <page-range>12-7</page-range>
            <pub-id pub-id-type="pmid">18552886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spivak</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Masked megaloblastic anemia.</article-title>
            <source>Arch Intern Med</source>
            <year>1982</year>
            <month>Nov</month>
            <volume>142</volume>
            <issue>12</issue>
            <fpage>2111</fpage>
            <page-range>2111-4</page-range>
            <pub-id pub-id-type="pmid">7138159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiao</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Roles of immune responses in the pathogenesis of immunorelated pancytopenia.</article-title>
            <source>Scand J Immunol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>e12911</fpage>
            <pub-id pub-id-type="pmid">32474938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26583.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagheri</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Labbani-Motlagh</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mirjalili</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karimzadeh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Khalili</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Types and outcomes of cytopenia in critically ill patients.</article-title>
            <source>J Comp Eff Res</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>9</issue>
            <fpage>627</fpage>
            <page-range>627-637</page-range>
            <pub-id pub-id-type="pmid">32495631</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
